Literature DB >> 11312102

Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers.

K Huang1, C Andersson, G M Roomans, N Ito, L Claesson-Welsh.   

Abstract

Vascular endothelial growth factor (VEGF-A) exerts its effects through receptor tyrosine kinases VEGF receptor-1 (VEGFR-1) and VEGFR-2, which are expressed on most endothelial cell types in vitro and in vivo. We have examined VEGF-A-induced signal transduction in porcine aortic endothelial (PAE) cells individually expressing VEGFR-1 or VEGFR-2, and cells co-expressing both receptor types. We show that VEGF-A-stimulated PAE cells co-expressing VEGFR-1 and -2 contain receptor heterodimers. VEGF-A-stimulation of all three cell lines (expressing VEGFR-1, -2 and -1/2) resulted in signal transduction with different efficiencies. Thus, tyrosine phosphorylation of phospholipase Cgamma, and accumulation of inositol polyphosphates were efficiently transduced in the VEGFR-1/2 cells whereas cells expressing VEGFR-1 responded poorly in these assays. In contrast, VEGF-A-induced activation of phosphoinositide 3-kinase and induction of Ca2+ fluxes were transduced well by VEGFR-1 and VEGFR-2 homo- and heterodimers. The pattern of Ca2+ fluxes was unique for each type of VEGF receptor dimer. Our data show that signal transduction induced by VEGF-A is transduced in distinct manners by homo- and heterodimers of VEGF receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312102     DOI: 10.1016/s1357-2725(01)00019-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  33 in total

Review 1.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.

Authors:  P I Imoukhuede; Aleksander S Popel
Journal:  Exp Cell Res       Date:  2010-12-23       Impact factor: 3.905

3.  Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.

Authors:  Zhao-Jun Liu; Takashi Shirakawa; Yan Li; Akinobu Soma; Masahiro Oka; G Paolo Dotto; Ronald M Fairman; Omaida C Velazquez; Meenhard Herlyn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

Authors:  Michael D Paul; Kalina Hristova
Journal:  Chem Rev       Date:  2018-12-27       Impact factor: 60.622

Review 5.  Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.

Authors:  Courtney K Domigan; Safiyyah Ziyad; M Luisa Iruela-Arispe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-02       Impact factor: 8.311

Review 6.  Vascular endothelial growth factor in heart failure.

Authors:  Ziad Taimeh; John Loughran; Emma J Birks; Roberto Bolli
Journal:  Nat Rev Cardiol       Date:  2013-07-16       Impact factor: 32.419

Review 7.  Vascular endothelial growth factor receptor-2 in breast cancer.

Authors:  Shanchun Guo; Laronna S Colbert; Miles Fuller; Yuanyuan Zhang; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2010-05-11

8.  Quantifying the strength of heterointeractions among receptor tyrosine kinases from different subfamilies: Implications for cell signaling.

Authors:  Michael D Paul; Hana N Grubb; Kalina Hristova
Journal:  J Biol Chem       Date:  2020-05-27       Impact factor: 5.157

9.  A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

Review 10.  Systems biology of vascular endothelial growth factors.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Microcirculation       Date:  2008-11       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.